| Hans-Günter Meyer-Thompson | Fentanyl
First Known Opiate Biomarker Shows Fentanyl's Effect on the Brain
First Known Opiate Biomarker Shows Fentanyl's Effect on the Brain
Fentanyl depresses breathing about 4 minutes before symptoms of distress are evident at a dose that is 1700 times lower than that needed for sedation, new research shows.
This new information comes after researchers identified a unique EEG signature produced by fentanyl, the first known biomarker of an opiate's effect on the brain. (Medscape, USA, 23.09.2022)